Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists

This program is made possible by an independent grant from Boehringer Ingleheim Pharmaceuticals, Inc. and Eli Lilly and Company.

This article summarizes collaborative strategies used by pharmacists to enhance chronic kidney disease screening, patient identification, and integration into diagnostic workflows, based on recommendations gleaned from roundtables of expert pharmacist stakeholders representing 23 different institutions.

View Issue